Skip to main content

Weening Michael's Form 4 filing

Calix, Inc (CALX) · filed Nov 3, 2025

Accession no.
0001678385-25-000013
Filed
Nov 3, 2025
Trade date
Oct 30-Nov 3, 2025
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $18.1M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Weening MichaelCIK 0001678385Director, Officer (President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 30, 2025Common StockMOption exerciseAcquired+200,000$7.84+$1,568,000216,117Direct
Oct 30, 2025Common StockSSaleDisposed−150,000$64.63F1−$9,694,50066,117Direct
Oct 30, 2025Common StockSSaleDisposed−50,000$67.55F2−$3,377,50016,117Direct
Nov 3, 2025Common StockMOption exerciseAcquired+74,000$7.84+$580,16090,117Direct
Nov 3, 2025Common StockSSaleDisposed−74,000$67.42F3−$4,989,08016,117Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 30, 2025Common StockMOption exerciseDisposed−200,000$0.00$074,000Direct
Nov 3, 2025Common StockMOption exerciseDisposed−74,000$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $64.55 to $65.00, inclusive. Full information on the number of shares sold at each sale price is available upon request.

Referenced by the price of 1 transaction in Table I.

F2

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $67.35 to $67.93, inclusive. Full information on the number of shares sold at each sale price is available upon request.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $66.245 to $69.450, inclusive. Full information on the number of shares sold at each sale price is available upon request.

Referenced by the price of 1 transaction in Table I.

Remarks

Sales reported on the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.

Read the full filing on SEC EDGAR (opens in a new tab)